Terns Pharmaceuticals Inc (NAS:TERN)
$ 5.88 -0.13 (-2.16%) Market Cap: 380.30 Mil Enterprise Value: 147.84 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 38/100

Terns Pharmaceuticals Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript

Dec 06, 2022 / 07:40PM GMT
Release Date Price: $5.86 (-3.78%)
Silven Tuerkcan
JMP Securities LLC - Analyst

Welcome to our annual JMP hematology and oncology conference. My name is Silven Tuerkcan. I'm a senior analyst at JMP Citizens. I cover precision medicines here. And if you would like to ask any question during today's call, please submit them via chat or you can e-mail me directly. Right now, it's my pleasure to host Erin Quirk, Head of R&D at Terns Pharmaceuticals. And in the background, we'll have Mark Vignola, CFO of Terns as well. Thank you so much. Thank you for joining us today.

Erin Quirk
Terns Pharmaceuticals, Inc. - President and Head of R&D

Thank you, Silven. It's our pleasure. We really appreciate the invitation.

Silven Tuerkcan
JMP Securities LLC - Analyst

Great. Thank you. So, to start off, I know you have a company and you span several indications here, but I would like to focus on your oncology programs today. Could you please talk about the BCR-ABL inhibitor landscape in CML and how your third generation TKI would fit into the existing space?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot